What is Human API?
Human API operates a sophisticated digital health data platform designed to bridge the gap between fragmented health information and the organizations that require it. By connecting, normalizing, and structuring data from a vast array of sources—including electronic health records (EHR), health information exchanges (HIEs), laboratories, and personal fitness devices—the company empowers stakeholders to build consumer-centric applications. Its primary market position is that of a neutral, secure intermediary that facilitates the seamless flow of health data, thereby accelerating innovation for health plans, digital therapeutics, and corporate wellness providers. The platform effectively solves the interoperability challenges that have historically hindered the adoption of personalized health services.
How much funding has Human API raised?
Human API has raised a total of $37M across 5 funding rounds:
Debt
$75K
Series A
$6.6M
Series B
$10M
Debt
$350K
Series C
$20M
Debt (2013): $75K with participation from Undisclosed
Series A (2015): $6.6M, investors not publicly disclosed
Series B (2019): $10M supported by Guardian Healthcare and Healthcare Ventures
Debt (2020): $350K featuring PPP
Series C (2020): $20M backed by Samsung NEXT company, CNO Financial Group, Inc., Moneta VC, and Allianz Life Insurance Company of North America
Key Investors in Human API
Allianz Life Insurance Company of North America
Established in 1890 and headquartered in Minneapolis, Minnesota, Allianz Life Insurance Company of North America provides annuities and life insurance products in the United States.
Guardian Healthcare
At Guardian Healthcare, we are committed to providing you and your family members with the highest level of care and respect as we serve you in your home.
Healthcare Ventures
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
What's next for Human API?
With the successful closure of its latest financing round, Human API is well-positioned to deepen its enterprise footprint and enhance its data normalization capabilities. The strategic focus will likely shift toward expanding its network of data partners and refining its API infrastructure to support more complex, real-time clinical use cases. As the industry moves toward more proactive, data-driven patient care, Human API's ability to provide a unified view of the consumer health journey will be instrumental. Future growth will likely involve scaling its presence in the clinical research and life insurance markets, where the demand for high-fidelity, longitudinal health data is reaching an inflection point. The company remains a key player to watch as it continues to set the standard for secure, consumer-permissioned health data exchange.
See full Human API company page
